0
0
0
0
1
2
3
$0
Is Cintas solid or fragile? The Finex Financial Health Scanner reads CTAS's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $11.3B |
|---|---|
| Net income | $2.0B |
| Operating margin | 23.1% |
| Net margin | 17.8% |
| Cash and investments | $289.0M |
| Total debt | $2.4B |
| Free cash flow | $1.7B |
| Revenue growth (1 year) | 8.9% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.